Toplantı Özeti


DOI :10.26650/JARHS2021-1138032   IUP :10.26650/JARHS2021-1138032    Tam Metin (PDF)

DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY

Güneş Esendağlı

Checkpoint blockade immunotherapy relies on the restoration of effector responses in precursor-exhausted T cells. Nevertheless, many inhibitory receptors are upregulated soon after the activation and reach high levels at effector phases. In addition to the functional status of type 1 helper T (Th1) cells, the timing and duration of PD-1 and CTLA-4 blockade are considered as critical factors for retaining T cell responsiveness. Here, we used a previously established ex-vivo model to display the decline in Th1 responses and to determine the state-of-function which may critically modulate the success of checkpoint blockade. In the absence of PD-1 and/or CTLA-4 blockade, proliferation and IFN-γ, TNF-α, IL-2 secretion capacities of Th1 cells were gradually abolished as the stimulation was continued. When applied at an early activation stage, the extension of blockade period interfered with the upregulation of multiple inhibitory receptors (PD-1, LAG3, TIM-3, and CTLA-4) and restricted Th1 hyporesponsiveness. The inhibitory receptors that were already expressed prior to the blockade were also downregulated potentially through an endocytic pathway. A time point representing the late stages of effector Th1 responses, which preceded the exhaustion, was determined as a therapeutic window for a short-term check point blockade. In conclusion, PD-1 and CTLA-4 checkpoint inhibitor therapy not only adjust the reactivation of hyporesponsive T cells but can also restrict the induction of de novo T cell exhaustion.


PDF Görünüm

Referanslar

    Atıflar

    Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


    DIŞA AKTAR



    APA

    Esendağlı, G. (2022). DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 5(1), 23-23. https://doi.org/10.26650/JARHS2021-1138032


    AMA

    Esendağlı G. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Sağlık Bilimlerinde İleri Araştırmalar Dergisi. 2022;5(1):23-23. https://doi.org/10.26650/JARHS2021-1138032


    ABNT

    Esendağlı, G. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, [Publisher Location], v. 5, n. 1, p. 23-23, 2022.


    Chicago: Author-Date Style

    Esendağlı, Güneş,. 2022. “DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi 5, no. 1: 23-23. https://doi.org/10.26650/JARHS2021-1138032


    Chicago: Humanities Style

    Esendağlı, Güneş,. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi 5, no. 1 (Dec. 2022): 23-23. https://doi.org/10.26650/JARHS2021-1138032


    Harvard: Australian Style

    Esendağlı, G 2022, 'DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY', Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol. 5, no. 1, pp. 23-23, viewed 5 Dec. 2022, https://doi.org/10.26650/JARHS2021-1138032


    Harvard: Author-Date Style

    Esendağlı, G. (2022) ‘DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY’, Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 5(1), pp. 23-23. https://doi.org/10.26650/JARHS2021-1138032 (5 Dec. 2022).


    MLA

    Esendağlı, Güneş,. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol. 5, no. 1, 2022, pp. 23-23. [Database Container], https://doi.org/10.26650/JARHS2021-1138032


    Vancouver

    Esendağlı G. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Sağlık Bilimlerinde İleri Araştırmalar Dergisi [Internet]. 5 Dec. 2022 [cited 5 Dec. 2022];5(1):23-23. Available from: https://doi.org/10.26650/JARHS2021-1138032 doi: 10.26650/JARHS2021-1138032


    ISNAD

    Esendağlı, Güneş. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY”. Sağlık Bilimlerinde İleri Araştırmalar Dergisi 5/1 (Dec. 2022): 23-23. https://doi.org/10.26650/JARHS2021-1138032



    ZAMAN ÇİZELGESİ


    Çevrimiçi Yayınlanma09.08.2022

    LİSANS


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    PAYLAŞ




    İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.